TNDM 250117 30.00P (TNDM250117P30000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

TNDM250117P30000

Watchlist

0.55
-0.40-42.11%

15min DelayClose Dec 20 16:00 ET

0.55High0.55Low

Intraday

5D
Daily

News

Express News | Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
BenzingaDec 20 15:55 ET
Express News | Tandem Diabetes Care Shares Are Trading Higher Amid Strength in Diabetes-related Stocks Following Weight Loss Data From Novo Nordisk
BenzingaDec 20 15:07 ET
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Seeking AlphaDec 20 12:10 ET
RBC Capital Remains a Buy on Tandem Diabetes Care (TNDM)
TipRanksDec 19 05:30 ET · Ratings
The Market Lifts Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares 25% But It Can Do More
Simply Wall StDec 18 05:01 ET
Citi Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $50
Moomoo NewsDec 11 07:31 ET · Ratings

Comments

mad541

Aug 2 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?